FDA Inspection
BioMarin International LimitedBioMarin International Limited – FDA Inspection, May 2, 2017
Record Details
This FDA Inspection record concerns BioMarin International Limited, with an inspection on May 2, 2017, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 041c9fb4-05a5-4075-a7c4-7a812bef61c2
Inspection Facts
- Inspection number
- 1010352
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of BioMarin International Limited
5| Date | Classification | Office | Project area |
|---|---|---|---|
| December 13, 2024 | Not classified | Office of Inspections and Investigations | |
| February 16, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 7, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 27, 2017 | Not classified | Office of Inspections and Investigations | |
| July 15, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for BioMarin International Limited
- FDA Inspection 1263534 - 2024-12-13
- FDA Inspection 1243568 - 2024-02-16
- FDA Inspection 1123865 - 2018-12-07
- FDA Inspection 1030194 - 2017-10-27
- FDA Inspection 981531 - 2016-07-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.